SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001477932-21-001370
Filing Date
2021-03-11
Accepted
2021-03-11 15:54:55
Documents
4
Period of Report
2020-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A bion_8ka.htm 8-K/A 23283
2 AUDITED FINANCIAL STATEMENTS bion_ex991.htm EX-99.1 220297
3 UNAUDITED FINANCIAL STATEMENTS bion_ex992.htm EX-99.2 200904
4 UNAUDITED PRO FORMA FINANCIAL INFORMATION bion_ex993.htm EX-99.3 175539
  Complete submission text file 0001477932-21-001370.txt   621396
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 60122126512
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-229399 | Film No.: 21733169
SIC: 8071 Services-Medical Laboratories